SCHEMBL16664837

SCHEMBL16664837

Cn1cc(-c2ccc(Cl)cc2)[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
GAA P10253 3/20 0.51
KDM4E B2RXH2 5/20 0.49
THRB P10828 2/20 0.49
HPGD P15428 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPT P10636 3/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
RAB9A P51151 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PDE10A Q9Y233 1/20 0.39
GCGR P47871 1/20 0.39
TP53 P04637 2/20 0.38
MCL1 Q07820 1/20 0.38
CRBN Q96SW2 1/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9880650 0.81 ERCC1 (0.49) ALDH1A1GAAKDM4ETDP1MAPT
SCHEMBL17881396 0.78 AURKA (0.44) GAAGCGRCRBN
SCHEMBL3918612 0.77 ALDH1A1 (0.51) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL3919676 0.73 DRD2 (0.56) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL4497139 0.72 ALDH1A1 (0.43) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL8228882 0.71 KDM4E (0.50) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL3446839 0.70 ALDH1A1 (0.45) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL7329537 0.67 ALDH1A1 (0.37) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL7729347 0.67 KDM4E (0.52) ALDH1A1GAAKDM4ETHRBHPGD
SCHEMBL4379053 0.66 DAO (0.43) ALDH1A1KDM4EHPGDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 EP disclosed
EP-3059235-B1 TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS SUMITOMO CHEMICAL CO (JP) 2020-10-28 EP disclosed
US-10085450-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-22 US disclosed
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-22 US disclosed
EP-3059235-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME Sumitomo Chemical Company, Ltd. (JP) 2016-08-24 EP disclosed
EP-3059235-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME Sumitomo Chemical Company, Ltd. (JP) 2016-08-24 EP disclosed
WO-2015056806-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME 住友化学株式会社 2015-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10085450-B2 Tetrazolinone compound and use thereof ROS1, TCOF1, RPS20 ALDH1A1 970/4885GAA 3368/4885KDM4E 1468/4885
US-20160270399-A1 TETRAZOLINONE COMPOUND AND USE THEREOF ROS1, TCOF1, RPS20 ALDH1A1 970/4885GAA 3368/4885KDM4E 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.